Indications and Usage Ozempic (semaglutide) injection 0.5 mg, 1 mg, or 2 mg and Ozempic (semaglutide) tablets 4 mg or 9 mg are indicated: as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes Ozempic injection is indicated: to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes and established CV disease to reduce the risk of sustained eGFR decline, end-stage kidney disease, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease Ozempic tablets are indicated: to reduce the risk of major adverse cardiovascular (CV) events (CV death, nonfatal myocardial infarction, or nonfatal stroke) in adults with type 2 diabetes who are at high risk for these events References: Ozempic injection

The occurrence is rare, according to both the report and a Long Island doctor, but is also the subject of multiple lawsuits, including two filed by Long Island patients who allege they developed vision loss after using semaglutide, the main ingredient in GLP-1 drugs
Key Benefits Long-Term Glycemic Stability : Successfully lowers HbA1c levels and helps maintain consistent blood sugar readings throughout the week
Sign up for The China Projects weekly newsletter, our free roundup of the most important China stories
Research over nearly a decade has shown that the GLP-1 drug semaglutide can lead to remarkable impacts on cardiovascular function in patients with Type 2 diabetes and/or overweight and obesity
Ozempic comes as a prefilled pen with multiple doses, so you can reuse the pen for a month with a new needle each time